Mercato Partners Acquisition Corp (MPRA) Peer Comparison
$11.73
As on 29-Sep-2023 16:00EDT
Market cap
$116 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
| Mercato Partners Acquisition Corp (MPRA) | MedTech Acquisition Corp (MTAC) | |
|---|---|---|
Market cap ($ Mln) |
116 | 84 |
Revenue ($ Mln) |
-- | -- |
Net Profit ($ Mln) |
5.61 | -1.13 |
Net Margin (%) |
92.08 | -31.78 |
RoE (%) |
4.15 | -- |
Price to Earnings |
-- | 226.80 |
Price-To-Book |
-- | 1.31 |
Income Statement ($ Mln)
| Mercato Partners Acquisition Corp (MPRA) | MedTech Acquisition Corp (MTAC) | |
|---|---|---|
|
Operating Revenue
|
0.00 | 0.00 |
|
Cost of Revenue
|
0.00 | 0.00 |
|
Gross Profit
|
-- | -- |
|
Operating Expenses
|
2.63 | 4.06 |
|
Operating Profit (EBIT)
|
-2.63 | -4.06 |
|
Other Income
|
6.09 | 3.55 |
|
Profit before Tax
|
6.76 | -0.51 |
|
Provision for Tax
|
0.75 | 0.61 |
|
Profit after Tax (Net Income)
|
5.61 | -1.13 |
|
Minority Interest
|
0.00 | 0.00 |
|
Consolidated Profit
|
5.01 | -1.13 |
Liabilities ($ Mln)
| Mercato Partners Acquisition Corp (MPRA) | MedTech Acquisition Corp (MTAC) | |
|---|---|---|
|
Shareholder's Funds
|
36.03 | -3.07 |
|
Minority Interest
|
0.00 | 0.00 |
|
Non-Current Liabilities
|
1.29 | 9.28 |
|
Current Liabilities
|
8.23 | 6.03 |
|
Total Liabilities
|
237.10 | 20.19 |
Assets ($ Mln)
| Mercato Partners Acquisition Corp (MPRA) | MedTech Acquisition Corp (MTAC) | |
|---|---|---|
|
Non-Current Assets
|
45.41 | 12.08 |
|
Current Assets
|
0.15 | 0.16 |
|
Total Assets
|
237.10 | 20.19 |
|
Total Debt*
|
2.01 | 3.33 |
|
Net Current Assets
|
-8.09 | -5.87 |
Cashflow ($ Mln)
| Mercato Partners Acquisition Corp (MPRA) | MedTech Acquisition Corp (MTAC) | |
|---|---|---|
|
Cash From Operating Activities
|
-0.94 | -2.74 |
|
Cash Flow from Investing Activities
|
-233.45 | 233.20 |
|
Cash from Financing Activities
|
0.60 | -230.51 |
|
Net Cash Inflow / Outflow
|
-233.78 | -0.05 |
Ratios
Profitability Ratios
| Mercato Partners Acquisition Corp (MPRA) | MedTech Acquisition Corp (MTAC) | |
|---|---|---|
|
ROCE (%)
|
6.12 | 4.56 |
|
ROE (%)
|
4.15 | 4.62 |
|
ROA (%)
|
3.89 | -0.83 |
|
EBIT Margin (%)
|
-- | -- |
|
Net Margin (%)
|
92.08 | -31.78 |
|
Cash Profit Margin (%)
|
-- | -- |
Growth Ratios
| Mercato Partners Acquisition Corp (MPRA) | MedTech Acquisition Corp (MTAC) | |
|---|---|---|
|
Revenue Growth (%)
|
-- | -- |
|
EBIT Growth (%)
|
-89.52 | 63.02 |
|
Net Profit Growth (%)
|
118.13 | -108.32 |
|
EPS Growth (%)
|
-- | -- |
|
Book Value Growth (%)
|
-- | -- |
Valuation Ratios
| Mercato Partners Acquisition Corp (MPRA) | MedTech Acquisition Corp (MTAC) | |
|---|---|---|
|
Price / Earnings
|
-- | -- |
|
Price / Book Value
|
-- | -- |
|
Dividend Yield (%)
|
-- | -- |
|
EV/EBITDA
|
-0.04 | 2.05 |
|
Market Cap ($ Cr)
|
-- | -- |
Solvency Ratios
| Mercato Partners Acquisition Corp (MPRA) | MedTech Acquisition Corp (MTAC) | |
|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.06 | -1.08 |
|
Current Ratio
|
0.02 | 0.03 |
|
Quick Ratio
|
0.02 | 0.03 |
|
Interest Coverage
|
2.07 | 0.94 |
Operating Efficiency Ratios
| Mercato Partners Acquisition Corp (MPRA) | MedTech Acquisition Corp (MTAC) | |
|---|---|---|
|
Debtors to sales (%)
|
-- | -- |
|
Asset Turnover
|
0.00 | 0.00 |
|
Receivable days
|
-- | -- |
|
Inventory Days
|
-- | -- |
|
Payable days
|
-- | -- |
|
Cash Conversion Cycle
|
-- | -- |